Bank of Nova Scotia’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-237,000
Closed -$3.36M 1076
2025
Q4
$3.36M Hold
237,000
0.01% 708
2025
Q3
$5.87M Sell
237,000
-406,877
-63% -$9.08M 0.01% 520
2025
Q2
$14.6M Buy
643,877
+274,877
+74% +$6.51M 0.03% 312
2025
Q1
$11.2M Buy
+369,000
New +$14.1M 0.03% 342
2023
Q2
Sell
-4,333
Closed -$313K 1019
2023
Q1
$313K Buy
+4,333
New +$338K ﹤0.01% 962
2018
Q2
Sell
-6,500
Closed -$255K 849
2018
Q1
$255K Buy
+6,500
New +$238K ﹤0.01% 871

Other funds holding ACHC

Bank of Nova Scotia's ACHC Position: Q1 2026 in Review

Bank of Nova Scotia sold out of Acadia Healthcare (ACHC) in Q1 2026, closing a stake of 237,000 shares — an estimated $3.36M sold.

Bank of Nova Scotia first reported a position in ACHC in Q1 2018 and held it in 6 quarters. The position peaked at $14.6M in Q2 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Bank of Nova Scotia reported no remaining Acadia Healthcare position as of Q1 2026 after selling out during the quarter.
  • Bank of Nova Scotia sold 237,000 Acadia Healthcare shares in Q1 2026, an estimated $3.36M.
  • Bank of Nova Scotia first reported a position in Acadia Healthcare in Q1 2018 and held it in 6 quarters.
  • Bank of Nova Scotia's Acadia Healthcare position peaked at $14.6M in Q2 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.